Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fish scale-derived hydroxyapatite for alveolar ridge preservation.

Biotechnology and applied biochemistry·2024
Same author

Safety and efficacy of tranexamic acid in children with cerebral palsy undergoing femoral varus derotational osteotomy: a double cohort study.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2020
Same author

Altered muscarinic receptor expression in the cerebral cortex of epileptic rats: restorative role of Withania somnifera.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2017
Same author

Cholinergic receptor alterations in the cerebral cortex of spinal cord injured rat.

Biochemistry and biophysics reports·2017
Same author

The effect of multimodal analgesia on minimum alveolar concentration of isoflurane for skin incision at constant bispectral index.

Anesthesia, essays and researches·2016
Same author

Oxidative stress and cell death in the cerebral cortex as a long-term consequence of neonatal hypoglycemia.

Canadian journal of physiology and pharmacology·2016

Related Experiment Video

Updated: May 1, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.4K

GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury.

J Shilpa1, C S Paulose

  • 1Department of Biotechnology, Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Cochin University of Science and Technology, Cochin, 682 022, Kerala, India.

Journal of Materials Science. Materials in Medicine
|April 1, 2014
PubMed
Summary

GABA and 5-HT chitosan nanoparticles promote liver cell proliferation and neuronal survival, restoring motor function in rats with liver injury. This highlights their therapeutic potential for liver diseases and associated neurological damage.

More Related Videos

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.1K

Related Experiment Videos

Last Updated: May 1, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.4K
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
07:48

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

Published on: October 13, 2018

7.1K

Area of Science:

  • Neuroscience
  • Hepatology
  • Nanomedicine

Background:

  • Hepatic injury causes metabolic alterations, leading to synaptic defects, neurodegeneration, and motor deficits.
  • Chitosan nanoparticles offer a potential delivery system for therapeutic agents targeting liver disease and neurological complications.

Purpose of the Study:

  • To evaluate GABA and 5-HT chitosan nanoparticles for liver cell proliferation and neuronal survival in partially hepatectomized rats.
  • To investigate the impact of these nanoparticles on neurotransmission and neurotrophic factors in the corpus striatum.
  • To assess the recovery of motor function following nanoparticle treatment.

Main Methods:

  • Partially hepatectomized rats were treated with GABA and 5-HT chitosan nanoparticles.
  • Liver cell proliferation was assessed using bromodeoxyuridine (BrdU) incorporation.
  • Neurotransmitter levels (GABAB, 5-HT2A), neurotrophic factors (CREB, GDNF, BDNF), and motor function (grid walk, rotarod) were evaluated.

Main Results:

  • Nanoparticle treatment promoted liver cell proliferation by modulating growth factors and cytokines.
  • GABA and 5-HT nanoparticles normalized GABAB and 5-HT2A neurotransmission in the corpus striatum.
  • Treatment facilitated neurogenesis and neuronal survival, leading to significant recovery of motor activity.

Conclusions:

  • GABA and 5-HT chitosan nanoparticles demonstrate therapeutic potential for liver-based diseases and associated striatal neuronal damage.
  • These nanoparticles can mitigate motor deficits by promoting liver regeneration and neuroprotection.
  • The study underscores the role of neurotransmitter modulation and neurotrophic support in managing liver injury-induced neurological dysfunction.